These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23077935)

  • 1. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
    Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
    Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
    Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer.
    Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D
    In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
    Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
    Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.
    De Vita F; Orditura M; Lieto E; Infusino S; Morgillo F; Martinelli E; Castellano P; Romano C; Ciardiello F; Catalano G; Pignatelli C; Galizia G
    Cancer; 2004 Jan; 100(2):270-8. PubMed ID: 14716760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
    Li ZP; Han JQ; Meng XW; Yang YF
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers.
    Li M; Liu F; Sun P; Gao Y; Chen H; Liu H; Wang M; Chen J; Zhao Y
    Hepatogastroenterology; 2012 Sep; 59(118):1865-8. PubMed ID: 22819906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
    Werther K; Christensen IJ; Nielsen HJ;
    Br J Cancer; 2002 Feb; 86(3):417-23. PubMed ID: 11875709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor.
    Lee JH; Ryu KW; Kim S; Bae JM
    Hepatogastroenterology; 2004; 51(60):1860-3. PubMed ID: 15532844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls.
    Ranieri G; Coviello M; Chiriatti A; Stea B; Montemurro S; Quaranta M; Dittadi R; Paradiso A
    Oncol Rep; 2004 Feb; 11(2):435-9. PubMed ID: 14719080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
    Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
    Gao ZL; Zhang C; Du GY; Lu ZJ
    Hepatogastroenterology; 2007; 54(77):1591-5. PubMed ID: 17708308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.